Señales en vivo de 600422.SS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 03:00):

Stats
Volumen de hoy	10.16M
Volumen promedio	9.22M
Capitalización de mercado	17.93B
EPS	CNY0.223 ( 2023-10-27 )
Próxima fecha de ganancias	( CNY0 ) 2024-06-28
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	40.83
ATR14	CNY0.0330 (0.14%)

Volumen Correlación

Largo: 0.56 (weak)

Corto: -0.80 (moderate negative)

Signal:(42.08) Neutral

KPC Pharmaceuticals, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

KPC Pharmaceuticals, Inc. Correlación - Moneda/Commodity

0.00
( neutral )

0.29
( neutral )

0.00
( neutral )

-0.01
( neutral )

0.46
( neutral )

0.61
( weak )

KPC Pharmaceuticals, Inc. Finanzas

Annual	2023
Ingresos:	CNY7.63B
Beneficio Bruto:	CNY3.28B (43.04 %)
EPS:	CNY0.590

FY	2023
Ingresos:	CNY7.63B
Beneficio Bruto:	CNY3.28B (43.04 %)
EPS:	CNY0.590

FY	2022
Ingresos:	CNY8.28B
Beneficio Bruto:	CNY3.44B (41.52 %)
EPS:	CNY0.510

FY	2021
Ingresos:	CNY8.25B
Beneficio Bruto:	CNY3.41B (41.30 %)
EPS:	CNY0.669

Financial Reports:

No articles found.

KPC Pharmaceuticals, Inc.

KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals, Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.